DuPont de Nemours, Inc. provided earnings guidance for the third quarter and full year of 2022. For the quarter, the company expects net sales to be between $3.17 billion and $3.37 billion and operating EBITDA to be about $810 million.

For the year, the company expects net sales guidance range to be between $13 billion and $13.4 billion reflecting a $200 million of incremental foreign currency headwinds, along with the removal of about $120 million in net sales related to the Biomaterials business, given its divestiture at the end of May.